Sandra Raimbault

Lille, FR 
Lille, FR 

Overview

Sandra Raimbault practices practicing medicine in Lille, France.

Her clinical expertise encompasses Medulloblastoma, Posterior Fossa Tumor, Embryonal Tumor with Multilayered Rosettes, and Brain Tumor.

She is actively involved in clinical research, co-authoring 14 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Lille, 59020, France
Other Locations
114, Rue Edouard Vaillant, Villejuif, 94805, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Enrollment Status: Completed
Publish Date: April 23, 2026
Intervention Type: Drug
Study Drugs: Cobimetinib, Atezolizumab
Study Phase: Phase 1/Phase 2
A Phase 1, Multicentre, Open-Label, Dose-Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Patients With Recurrent or Refractory Solid Tumours
A Phase 1, Multicentre, Open-Label, Dose-Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Patients With Recurrent or Refractory Solid Tumours
Enrollment Status: Terminated
Publish Date: January 21, 2026
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

14 Total Publications

Challenges and needs among pediatric oncology providers in caring for pediatric brain tumor patients and survivors: A qualitative study.
Challenges and needs among pediatric oncology providers in caring for pediatric brain tumor patients and survivors: A qualitative study.
Journal: International journal of clinical and health psychology : IJCHP
Published: March 16, 2026

Frequently Asked Questions about Sandra Raimbault

Is Sandra Raimbault a top-rated expert for Medulloblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Sandra Raimbault is classified as an Experienced expert for Medulloblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sandra Raimbault participate in research or clinical trials?

Yes. Sandra Raimbault has published 14 articles and abstracts on conditions like Medulloblastoma. You can view a list of Sandra Raimbault's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Raimbault's expertise for a condition
ConditionClose
        View All 11 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile